On Friday, November 20, President Trump announced two interim rules that he claims will lower drug costs in Medicare Parts B and D. That is not accurate.
Most Favored Nation Policy Is Unfavorable to U.S. Biopharmaceutical Research
Back in September, President Trump signed an Executive Order ordering the Department of Health and Human Services to implement a most favored nation (MFN) policy for pharmaceutical reimbursement in Medicare.
Biden Advisor Emanuel Has the Wrong Prescription for COVID-19 Vaccine
Dr. Ezekiel Emanuel is remembered for being a chief architect of Obamacare and penning an article “Why I Hope to Die at 75.” Will he determine who gets a COVID-19 vaccine first?
Government-Run Healthcare During COVID-19
A Wall Street Journal editorial, “Europe’s Covid Hospital Lesson: How Government Health Care Has Led to Funding Caps and Too Few ICU Beds,” provided an interesting analysis on socialized medicine and COVID-19.
Bidencare: A Straight Line to Government-Run Healthcare
Former Vice President Biden argued in his recent debate with President Trump that he does not want “Medicare for All” but wants “Bidencare” where a public option would be added to the Patient Protection and Affordable Care Act (ACA). But that’s a straight line to government-run healthcare.
Those With Pre-Existing Conditions Will Be Protected
Democrats continue to declare that President Trump and his fellow Republicans want to deny healthcare to millions of Americans, especially those with pre-existing conditions. It’s not true.
Problems Continue with 340B Program
Berkeley Research Group report shows once again how 340B has been corrupted and is being abused.
President Trump’s New Executive Order: Deserves Praise and Raises Questions
President Trump has announced a new EO, the “America-First Healthcare Plan” and lists the great accomplishments achieved in healthcare reform, but also raises questions and concerns.
Canada Just Says No to Drug Importation
The OMB is reviewing the final rule that would allow states to import drugs from Canada.
Most Favored Nation Policy: Unfavorable to U.S. Pharmaceutical Research
President Trump signs controversial Executive Order (EO) implementing “most favored nation” policy to lower drug costs.